Multitarget Therapeutics for Neurodegenerative Diseases.
| dc.contributor.author | Gabr, Moustafa T | |
| dc.contributor.author | Yahiaoui, Samir | |
| dc.date.accessioned | 2020-10-21T13:16:49Z | |
| dc.date.available | 2020-10-21T13:16:49Z | |
| dc.date.issued | 2020-01-19 | |
| dc.identifier.citation | Biomed Res Int. 2020 Jan 19;2020:6532827. doi: 10.1155/2020/6532827 | en_US |
| dc.identifier.pmid | 32695817 | |
| dc.identifier.doi | 10.1155/2020/6532827 | |
| dc.identifier.uri | http://hdl.handle.net/10033/622525 | |
| dc.description.abstract | No abstract available | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Hindawi | en_US |
| dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
| dc.title | Multitarget Therapeutics for Neurodegenerative Diseases. | en_US |
| dc.type | Editorial | en_US |
| dc.identifier.eissn | 2314-6141 | |
| dc.contributor.department | HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany. | en_US |
| dc.identifier.journal | BioMed research international | en_US |
| dc.source.volume | 2020 | |
| dc.source.beginpage | 6532827 | |
| dc.source.endpage | ||
| refterms.dateFOA | 2020-10-21T13:16:50Z | |
| dc.source.journaltitle | BioMed research international | |
| dc.source.country | United States |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International